Subscribe to Seeking Alpha feed
https://seekingalpha.com
URL: https://seekingalpha.com
Updated: 2 hours 56 min ago

SA analyst upgrades/downgrades: TSLA, DIS, NKE, MSFT

Thu, 09/10/2026 - 10:09

U.S. Bancorp: Dividend Increase Supports Income Appeal

Thu, 09/10/2026 - 10:08

Northern Oil and Gas: My Conviction Holds As Unit Economics Strengthen In Q2

Thu, 09/10/2026 - 10:07

Pop Mart International: Falling Consumer Interest Leads To Bleak Outlook

Thu, 09/10/2026 - 09:59

RWE: A Reflection On How Overvalued The Company Now Is

Thu, 09/10/2026 - 09:56

PGIM Real Assets Fund Q2 2026 Commentary

Thu, 09/10/2026 - 09:46

LiDAR's Falling Costs Challenge Tesla's Robotaxi Valuation, Consider TSLQ

Thu, 09/10/2026 - 09:22

Royal Caribbean: Macro Risks Dominate, But The Stock Has Overcorrected

Thu, 09/10/2026 - 09:18

September Fed hike odds jump after the latest PPI inflation print

Thu, 09/10/2026 - 09:15

Sony: Quiet Quality, Stealthy Growth

Thu, 09/10/2026 - 09:15

Baron Partners Fund Q2 2026 Contributors And Detractors

Thu, 09/10/2026 - 09:15

1-800-Flowers shares slide after weak Q4

Thu, 09/10/2026 - 09:14

Cisco, Infleqtion target quantum breakthrough with new networking pact

Thu, 09/10/2026 - 09:13

Hartford Multi-Asset Income Fund Q2 2026 Commentary

Thu, 09/10/2026 - 09:13

Groupon: Testing Investors' Patience, But New Product Innovations May Drive Hope

Thu, 09/10/2026 - 09:12

Wholesale inventories accelerate, as expected, in July

Thu, 09/10/2026 - 09:11

Superior Group Of Companies Is Cheap Even After Shares Shot Higher

Thu, 09/10/2026 - 09:10

Darling Ingredients: Turnaround Is Just Getting Started

Thu, 09/10/2026 - 09:10

Baron Partners Fund Q2 2026 Shareholder Letter

Thu, 09/10/2026 - 09:10

Tyra Biosciences, Inc. (TYRA) Discusses Initial SURF302 Results on Oral Dabogratinib for Intermediate Risk NMIBC - Slideshow

Thu, 09/10/2026 - 09:07

Pages